Preferred Label : temsirolimus;

MeSH note : structure in first source; inhibits mTOR protein;

CISMeF synonym : CCI 779; torisel; wyeth brand of temsirolimus;

MeSH synonym : rapamycin, 42-(3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate);

MeSH hyponym : CCI-779;

MeSH CAS label : rapamycin 42-(2,2-bis(hydroxymethyl)propionate);

Is substance : O;

UNII : 624KN6GM2T;

InChIKey : CBPNZQVSJQDFBE-FUXHJELOSA-N;

Details


Main resources

You can consult :


https://www.ema.europa.eu/medicines/human/EPAR/Torisel
2012
false
United Kingdom
French
English
syndication feed
antineoplastic agents
sirolimus
drug evaluation
treatment outcome
infusions, intravenous
orphan drug production
pharmaceutical solutions
carcinoma, renal cell
adult
child
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
drug incompatibility
drug storage
drug compounding
drug labeling
drug approval
sirolimus
TOR Serine-Threonine kinases
protein kinase inhibitors
protein kinase inhibitors
temsirolimus
temsirolimus
temsirolimus
package leaflet
summary of product characteristics
drug evaluation

---
https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/torisel-1439.html
2012
false
Canada
English
French
drug evaluation
evaluation of the transparency committee
temsirolimus
infusions, intravenous
carcinoma, renal cell
treatment outcome
Cost-Benefit analysis
antineoplastic agents
protein kinase inhibitors
temsirolimus
sirolimus
TOR Serine-Threonine kinases
neoplasm metastasis

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailOne.php?lang=fr&linkID=SBD00148
2011
false
false
false
Canada
drug information
temsirolimus

---
http://www.has-sante.fr/portail/jcms/c_946059/torisel-temsirolimus-inhibiteur-de-proteine-kinase
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-03/torisel_-_ct-7303.pdf
2010
false
France
French
sirolimus
infusions, intravenous
orphan drug production
antineoplastic agents
carcinoma, renal cell
lymphoma, mantle-cell
temsirolimus
neoplasm recurrence, local
adult
aged
treatment outcome
temsirolimus
antineoplastic agents
protein kinase inhibitors
temsirolimus
protein kinase inhibitors
evaluation of the transparency committee
guidelines for drug use

---
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2008/14039a-fra.php
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2008/14524a-fra.php
2008
Canada
French
English
sirolimus
canada
drug hypersensitivity
infusions, intravenous
drug hypersensitivity
antineoplastic agents
temsirolimus
pharmacovigilance note

---
https://pgtmsite.files.wordpress.com/2024/01/temsirolimus_es_20080612.pdf
2008
Canada
drug information
temsirolimus
temsirolimus
Temsirolimus

---
Nous contacter.
19/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.